Flotek Provides Strong 2025 Outlook in Connection with Announcing Robust First Quarter 2025 Revenue and Profit Growth

HOUSTON, May 6, 2025 /PRNewswire/ -- Flotek Industries, Inc. ("Flotek" or the "Company") (NYSE: FTK) today announced operational and financial results for the quarter ended March 31, 2025. First quarter 2025 results were the strongest quarterly results in terms of revenue, gross profit, net income and adjusted EBITDA ((1)) in the last 5 years.

Financial Summary (in thousands, except 'per share' amounts)


                                               Three Months Ended March 31,


                                          2025                      2024    % Change




               
            Total Revenues $55,362                   $40,374        37 %


                 
            Gross Profit $12,449                    $8,821        41 %


                   
            Net Income  $5,380                    $1,562       244 %


     
     Diluted Income (Loss) Per Share   $0.17                     $0.05       240 %


          
            Adjusted EBITDA (1)  $7,780                    $4,026        93 %

Highlights

    --  In April 2025, we acquired 30 real-time gas monitoring and dual fuel
        optimization assets for mobile power generation (22 in-service and 8
        under construction, expected by year-end) and related Intellectual
        Property and executed a $160 million multi-year contract.
    --  First quarter 2025 results represented the fifth consecutive quarter of
        growth in revenue, gross profit, net income and adjusted EBITDA ((1)).
    --  Total revenue rose 37% vs. first quarter 2024, as a result of an 88%
        increase in external chemistry revenue and a 57% increase in Data
        Analytics revenue.
    --  Gross profit climbed 41% vs. first quarter 2024, with first quarter 2025
        gross profit margin rising to 23%.
    --  Net income was $5.4 million and adjusted EBITDA((1)) totaled $7.8
        million, up 244% and 93%, respectively, vs. first quarter 2024.

2025 Outlook

In 2024, our total revenue was $187.0 million, our net income was $10.5 million and our adjusted EBITDA((1)) was $20.3 million. As a result of our continued growth during the first quarter of 2025 and the impact of our recently announced acquisition of mobile power generation assets and subsequent long-term lease, Flotek expects increased revenues and profitability in 2025, as compared to 2024, and initiates the following 2025 guidance metrics:

    --  Total Revenue between $200 million and $220 million
    --  Adjusted EBITDA((2)) between $34 million and $39 million

The mid-points of the ranges above represent increases of 12% and 80%, as compared to the respective metrics in 2024.

Management Commentary

Chief Executive Officer Dr. Ryan Ezell commented, "The first quarter of 2025 marks another significant step in the execution of our corporate strategy towards the convergence of innovative Data and Chemistry solutions that deliver unprecedented value to our customers and external stakeholders. We have now grown revenue, net income and adjusted EBITDA in five consecutive quarters. Combining these outstanding results with our recently announced transformative expansion into enhanced real-time data monitoring and gas conditioning in the mobile power generation sector, positions Flotek to deliver an exceptionally strong 2025 and beyond for its shareholders.

Looking ahead, Flotek will continue to advance technologies that empower our customers' assets to maximize returns, reduce costs, automate processes, and utilize data in ways previously unimaginable. Our relentless pursuit to leverage chemistry as the common value creation platform will position Flotek as a leader in differentiated technologies and foster our future growth."

First Quarter 2025 Financial Results

    --  Revenue: Flotek reported total revenues of $55.4 million for the first
        quarter of 2025, an increase of $15 million, or 37%, compared to total
        revenues of $40.4 million for the first quarter of 2024. First quarter
        2025 revenue includes $7.5 million related to the minimum purchase
        requirements (the "Minimum Purchase Requirements") under the Company's
        long-term supply agreement with ProFrac Services, LLC.

Segment Revenue Summary (in thousands)


                                                   Three Months Ended March 31,


                                              2025                   2024       % Change




                   Chemistry Technologies:



     External Revenues                    $22,009                $11,685           88 %



     Related Party Revenues                30,729                 27,014           14 %



     Total                                $52,738                $38,699           36 %





     
                Data Analytics:



     Product Revenues                      $1,662                   $933           78 %



     Service Revenues                         962                    742           30 %



     Total                                 $2,624                 $1,675           57 %

    --  Gross Profit: The Company generated gross profit of $12.4 million during
        the first quarter of 2025 compared to $8.8 million during the first
        quarter of 2024. The improvement in first quarter 2025 gross profit was
        primarily the result of a 36% increase in Chemistry Technologies revenue
        and a 57% increase in Data Analytics revenue, as compared to the first
        quarter of 2024. The improvement in gross profit was achieved despite a
        14% decline in revenue attributable to the Minimum Purchase Requirements
        as compared to the first quarter of 2024.
    --  Selling, General and Administrative ("SG&A") Expense: SG&A expense
        totaled $6.3 million for the first quarter of 2025, or 11% as a
        percentage of revenues, compared to $6.1 million during the first
        quarter of 2024, or 15 % as a percentage of revenues.
    --  Net Income and EPS: Flotek reported net income of $5.4 million, or $0.17
        per diluted share, for the first quarter of 2025. This compares to net
        income of $1.6 million, or $0.05 per diluted share, for the first
        quarter of 2024.
    --  Adjusted EBITDA (Non-GAAP)((1)): Adjusted EBITDA was $7.8 million in the
        first quarter of 2025 as compared to $4.0 million in the first quarter
        of 2024. This marks the 10th consecutive quarter of adjusted EBITDA
        improvement.



     (1) See the "Unaudited Reconciliation of Non-GAAP Items and Non-Cash Items Impacting Earnings" section in this release for more information
            about this measure, including reconciliations to the most comparable GAAP measures.



     (2) A non-GAAP financial measure. See the "Unaudited Reconciliation of Non-GAAP Items and Non-Cash Items Impacting Earnings" section in this
            release for more information about this measure. We are unable to reconcile this forward-looking non-GAAP financial measure to the most
            directly comparable GAAP financial measure without unreasonable efforts, as we are unable to predict with a reasonable degree of certainty
            the impact of certain items that would be expected to impact the GAAP financial measure, including, among other items, certain stock-based
            compensation costs and the impact of the revaluation of certain liabilities, which is based upon our future stock price. These items do not
            impact the non-GAAP financial measure.

Conference Call Details

The Company plans to host its earnings conference call on Wednesday, May 7, 2025, at 9:00 a.m. CDT (10:00 a.m. EDT).

Participants may access the call through Flotek's website at www.flotekind.com under "News and Events" within the Investor Relations section, by telephone toll free at 1-800-836-8184 (international toll: 1-646-357-8785), or by using the following link to access the audience view of the webcast at https://app.webinar.net/KGZnYV43MXw approximately five minutes prior to the start of the call. Following the conclusion of the conference call, a recording of the call will be available on the Company's website.

About Flotek Industries, Inc.

Flotek Industries, Inc. is a leading chemistry and data technology company focused on servicing the Energy industry. The Company's top tier technologies leverage near real-time data to deliver innovative solutions to maximize customer returns. Flotek has an intellectual property portfolio of over 130 patents, 20+ years of field and laboratory data, and a global presence in more than 59 countries.

Flotek has established collaborative partnerships focused on sustainable and optimized chemistry and data solutions, aiming to reduce the environmental impact of energy on land, air, water and people.

Flotek is based in Houston, Texas and its common shares are traded on the New York Stock Exchange under the ticker symbol "FTK." For additional information, please visit www.flotekind.com.

Forward-Looking Statements

Certain statements set forth in this press release constitute forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934) regarding Flotek Industries, Inc.'s business, financial condition, results of operations and prospects. Words such as will, continue, expects, anticipates, intends, plans, believes, seeks, estimates and similar expressions or variations of such words are intended to identify forward-looking statements, but are not the exclusive means of identifying forward-looking statements in this press release. Although forward-looking statements in this press release reflect the good faith judgment of management, such statements can only be based on facts and factors currently known to management. Consequently, forward-looking statements are inherently subject to risks and uncertainties, and actual results and outcomes may differ materially from the results and outcomes discussed in the forward-looking statements. Further information about the risks and uncertainties that may impact the Company are set forth in the Company's most recent filing with the Securities and Exchange Commission on Form 10-K (including, without limitation, in the "Risk Factors" section thereof), and in the Company's other SEC filings and publicly available documents. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to revise or update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this press release.


                                                                        
              
                FLOTEK INDUSTRIES, INC.

                                                            
              
                 UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

                                                                   
              
                (in thousands, except share data)




                                                                                                                                     March 31, 2025 December 31, 2024


                                                                                
              
                ASSETS



     Current assets:



     Cash and cash equivalents                                                                                                              $6,253             $4,404



     Restricted cash                                                                                                                           102                102



     Accounts receivable, net of allowance for credit losses of $460 and $447 at                                                            19,809             17,386


     March 31, 2025 and December 31, 2024, respectively



     Accounts receivable, related party, net of allowance for credit losses of $0 at                                                        48,246             52,370


     each of March 31, 2025 and December 31, 2024, respectively



     Inventories, net                                                                                                                       13,691             13,303



     Other current assets                                                                                                                    3,464              2,952



     Current contract asset                                                                                                                  5,782              5,939



     Total current assets                                                                                                                   97,347             96,456



     Long-term contract asset                                                                                                               61,781             63,105



     Property and equipment, net                                                                                                             6,426              6,178



     Operating lease right-of-use assets                                                                                                     3,008              3,326



     Deferred tax assets, net                                                                                                                   38                 51



     Other long-term assets                                                                                                                  1,637              1,680



     
                TOTAL ASSETS                                                                                                            $170,237           $170,796




                                                                 
              
                LIABILITIES AND STOCKHOLDERS' EQUITY



     Current liabilities:



     Accounts payable                                                                                                                      $38,967            $38,073



     Accrued liabilities                                                                                                                     3,975              5,912



     Income taxes payable                                                                                                                      130                 48



     Current portion of operating lease liabilities                                                                                          1,316              1,486



     Asset-based loan                                                                                                                            -             4,789



     Current portion of long-term debt                                                                                                          15                 60



     Total current liabilities                                                                                                              44,403             50,368



     Deferred revenue, long-term                                                                                                                14                 14



     Long-term operating lease liabilities                                                                                                   6,116              6,514



     
                TOTAL LIABILITIES                                                                                                         50,533             56,896



     Commitments and contingencies



     Stockholders' equity:



     Preferred stock, $0.0001 par value, 100,000 shares authorized; no shares                                                                    -


        issued and outstanding



     Common stock, $0.0001 par value, 240,000,000 shares authorized;                                                                             3                  3


        30,940,761 shares issued and 29,826,816 shares outstanding at March


        31, 2025; 30,938,073 shares issued and 29,826,508 shares outstanding


        at December 31, 2024



     Additional paid-in capital                                                                                                            465,112            464,620



     Accumulated other comprehensive income                                                                                                    206                251



     Accumulated deficit                                                                                                                 (310,928)         (316,308)



     Treasury stock, at cost; 1,113,945 and 1,111,565 shares at March 31, 2025                                                            (34,689)          (34,666)


        and December 31, 2024, respectively



     Total stockholders' equity                                                                                                            119,704            113,900



     
                TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY                                                                              $170,237           $170,796


                                     
              
                FLOTEK INDUSTRIES, INC.

                    
              
                Unaudited Condensed Consolidated Statements of Operations

                              
              
                (in thousands, except per share data)




                                                                                                              Three Months Ended March 31,


                                                                                                         2025                   2024



     
                Revenue:



     Revenue from external customers                                                                 $24,423                $13,180



     Revenue from related party                                                                       30,939                 27,194



     
                Total revenues                                                                      55,362                 40,374



     
                Cost of goods sold                                                                  42,913                 31,553



     
                Gross profit                                                                        12,449                  8,821



     
                Operating costs and expenses:



     Selling, general, and administrative                                                              6,282                  6,087



     Depreciation                                                                                        252                    220



     Research and development                                                                            355                    406



     Gain on sale of property and equipment                                                              (7)



     Total operating costs and expenses                                                                6,882                  6,713



     
                Income from operations                                                               5,567                  2,108



     
                Other income (expense):



     Interest expense                                                                                  (229)                 (278)



     Other income (expense), net                                                                         106                   (26)



     Total other expense                                                                               (123)                 (304)



     
                Income before income taxes                                                           5,444                  1,804



     Income tax expense                                                                                 (64)                 (242)



     
                Net income                                                                          $5,380                 $1,562





     
                Income per common share:



     Basic                                                                                             $0.18                  $0.05



     Diluted                                                                                           $0.17                  $0.05





     
                Weighted average common shares:



     Weighted average common shares used in                                                           29,683                 29,431


        computing basic income per common share



     Weighted average common shares used in                                                           31,752                 30,316


        computing diluted income per common share


                                                                       
              
                FLOTEK INDUSTRIES, INC.

                                                      
              
                UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

                                                                           
              
                (in thousands)




                                                                                                                                                 Three Months Ended March 31,


                                                                                                                                            2025               2024



     
                Cash flows from operating activities:



     Net income                                                                                                                          $5,380             $1,562



     Adjustments to reconcile net income to net cash provided by operating activities:



     Change in fair value of contingent consideration                                                                                     (125)              (26)



     Amortization of contract asset                                                                                                       1,482              1,267



     Depreciation                                                                                                                           252                220



     Amortization of asset-based loan origination costs                                                                                      71                 85



     Provision for credit losses, net of recoveries                                                                                          66                 32



     Provision for excess and obsolete inventory                                                                                             64                285



     Gain on sale of property and equipment                                                                                                 (7)



     Non-cash lease expense                                                                                                                 318                694



     Stock compensation expense                                                                                                             461                311



     Deferred income tax expense                                                                                                             14                209



     Changes in current assets and liabilities:



     Accounts receivable                                                                                                                (2,489)             2,937



     Accounts receivable, related party                                                                                                   4,124            (4,086)



     Inventories                                                                                                                          (354)           (1,318)



     Other assets                                                                                                                         (540)               856



     Accounts payable                                                                                                                       893              4,246



     Accrued liabilities                                                                                                                (1,811)           (2,499)



     Operating lease liabilities                                                                                                          (568)             (921)



     Income taxes payable                                                                                                                    82                 33



     Net cash provided by operating activities                                                                                            7,313              3,887



     
                Cash flows from investing activities:



     Capital expenditures                                                                                                                 (598)             (152)



     Proceeds from sale of assets                                                                                                             7



     Net cash used in investing activities                                                                                                (591)             (152)



     
                Cash flows from financing activities:



     Payments on long term debt                                                                                                            (45)              (45)



     Proceeds from asset-based loan                                                                                                      53,345             38,800



     Payments on asset-based loan                                                                                                      (58,136)          (43,181)



     Payments to tax authorities for shares withheld from employees                                                                        (23)               (9)



     Proceeds from issuance of stock under Employee Stock Purchase Plan                                                                      31                 33



     Payments for finance leases                                                                                                              -               (9)



     Net cash used in financing activities                                                                                              (4,828)           (4,411)



     
                Effect of changes in exchange rates on cash and cash equivalents                                                         (45)                42



     
                Net change in cash and cash equivalents and restricted cash                                                             1,849              (634)



     Cash and cash equivalents at the beginning of period                                                                                 4,404              5,851



     Restricted cash at the beginning of period                                                                                             102                102



     
                Cash and cash equivalents and restricted cash at beginning of period                                                    4,506              5,953



     Cash and cash equivalents at end of period                                                                                           6,253              5,219



     Restricted cash at the end of period                                                                                                   102                100



     
                Cash and cash equivalents and restricted cash at end of period                                                         $6,355             $5,319


                                      
              
                FLOTEK INDUSTRIES, INC.

          
              
                Unaudited Reconciliation of Non-GAAP Items and Non-Cash Items Impacting Earnings

                                           
              
                (in thousands)




                                                                                                          Three Months Ended March 31,        Twelve Months Ended

                                                                                                                                       December 31,


                                                                                                 2025                       2024                        2024





     
                Gross profit                                                               $12,449                     $8,821                     $39,386



     Stock compensation expense                                                                   21                          4                          24



     Severance and retirement                                                                     38                          9                          11



     Contingent liability revaluation                                                          (125)                      (26)                         71



     Amortization of contract asset                                                            1,482                      1,267                       5,612



     
                Adjusted Gross profit (Non-GAAP) (1)                                       $13,865                    $10,075                     $45,104





     
                Net income                                                                  $5,380                     $1,562                     $10,498



     Interest expense                                                                            229                        278                       1,095



     Income tax expense                                                                           64                        242                         649



     Depreciation and amortization                                                               252                        220                         891



     
                EBITDA (Non-GAAP) (1)                                                       $5,925                     $2,302                     $13,133



     Stock compensation expense                                                                  461                        311                       1,366



     Severance and retirement                                                                     44                         12                          39



     Contingent liability revaluation                                                          (125)                      (26)                         71



     Gain on disposal of asset                                                                   (7)                                                (124)



     Amortization of contract asset                                                            1,482                      1,267                       5,612



     Non-Recurring professional fees                                                                                       160                         230



     
                Adjusted EBITDA (Non-GAAP) (1)                                              $7,780                     $4,026                     $20,327




     (1) Management believes that adjusted gross profit, EBITDA and adjusted EBITDA for the three months ended March 31, 2025 and 2024, and for the
            twelve months ended December 31,2024 are useful to investors to assess and understand operating performance, especially when comparing those
            results with previous and subsequent periods.  Management views the income and expenses noted above to be outside of the Company's normal
            operating results.  Management analyzes operating results without the impact of the above items as an indicator of performance, to identify
            underlying trends in the business and cash flow from continuing operations, and to establish financial and operational goals, excluding
            certain non-cash or non-recurring items.

View original content to download multimedia:https://www.prnewswire.com/news-releases/flotek-provides-strong-2025-outlook-in-connection-with-announcing-robust-first-quarter-2025-revenue-and-profit-growth-302447702.html

SOURCE Flotek Industries, Inc.